NCT06642025
- Conditions
- Acute Myeloid Leukemia (AML), CAR-T, Hematologic Diseases, +6 more
- Locations
-
- The Second Affliated Hospital of Anhui Medical University Hefei, Anhui, China
Clinical trial condition
Acute Myeloid Leukemia (AML)
Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.
146 public trials
43 recruiting studies
Acute Myeloid Leukemia (AML) trial results
NCT04275518
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- The First Hospital of Peking University Beijing, Beijing Municipality, China
- Guangzhou panyu central hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Henan Provincial Oncology Hospital Zhengzhou, Henan, China
NCT06550713
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Peking University international Hospital Beijing, Beijing Municipality, China
- The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
- Harbin The First Hospital Harbin, Heilongjiang, China
Enrolling by Invitation
Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
NCT07651163
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China
Not Yet Recruiting
Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse
NCT07686965
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematopoetic Stem Cell Transplantation, +7 more
- Locations
-
Not specified
Not Yet Recruiting
VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.
NCT07642453
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
Not specified
Not Yet Recruiting
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
NCT07302776
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
- Locations
-
- Stanford University Palo Alto, California, United States
Not Yet Recruiting
VAH vs VA in Newly Diagnosed Elderly AML
NCT07469046
- Conditions
- Acute Myeloid Leukemia (AML), Elderly Patients (60-75 Years), Hematologic Diseases, +6 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)
NCT07507825
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University Hangzhou, Zhejiang, China
Not Yet Recruiting
Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients
NCT07505160
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China